Other clinical-pathologic factors known to be associated with IDH1/2 WT gliomas, such as 1p/19q non-codeletion status, astrocytoma histology and older age, were also identified to significantly correlate with TAGLN2 expression in the TCGA analysis (Table 1). This evidence concerns the gene TAGLN2 and central nervous system cancer.